Clinical Trial Update: Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 study of a house dust mite allergen vaccine in patients with perennial allergic rhinitis and asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Perennial Allergic Rhinitis

Drugs mentioned

• House dust mite allergen vaccine

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Perennial Allergic Rhinoconjunctivitis, Allergic Asthma | Phase 1, Phase 2 | Status: COMPLETED